Parag Milk Foods Limited

Similar documents
Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Amber Enterprises India Ltd

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Quick take. Parag Milk Foods BUY. Expanding dairy industry to unleash huge potential. CMP Target Price `277 ` year daily price chart

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Procter & Gamble Hygiene & Health Care

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Hindustan Media Ventures

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Future Supply Chain Solutions Ltd

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Mahindra & Mahindra Ltd.

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Safari Industries BUY. On a fast paced Safari. Initiating Coverage Luggage February 21, CMP Target Price `532 ` year daily price chart

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Avenue Supermarts Limited

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

MISHRA DHATU NIGAM Ltd.

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Newgen Software Technologies Ltd

Century Plyboards Ltd

Transport Corporation of India

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Apollo Micro Systems Ltd

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Tata Consultancy Services (TCS)

Varroc Engineering Ltd.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Lupin 1QFY2018 Result Update

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Aster DM Healthcare Ltd

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Sandhar Technologies Limited

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Dr. Reddy s Laboratories

Adlabs Entertainment AVOID. IPO Note Valuation expensive; Avoid. Issue Open: March 10, 2015 Issue Close: March 12, 2015

Dewan Housing Finance

SUN TV Network NEUTRAL. Performance Highlights CMP. `297 Target Price - 1QFY2013 Result Update Media. Investment Period -

Simplex Infrastructures

GlaxoSmithKline Pharmaceuticals

FY2017 FY2018E FY2019E

Aurobindo Pharma BUY. Performance Highlights CMP. `580 Target Price `823. 4QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights. `708 Target Price CMP `823. 2QFY2018 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights CMP. `686 Target Price `877. 3QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Transcription:

May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 Initiating coverage Dairy products April 16, 2018 Parag Milk Foods Limited Evolving into a dairy FMCG brand story.. Parag Milk Foods (PARAG) is one of the leading dairy products companies in India. The company has been successful in creating strong brands like GO, Gowardhan and in introducing new products like Whey Protein. It has become the 2nd player in processed cheese (after Amul) in a short span of 10 years and commands 33% market share. Rising revenue share of high-margin value added products (VAP) is likely to boost its margins in coming years. Favorable market dynamics: Indian dairy industry is valued at ~`600000 cr, growing at 10%+CAGR which presents a strong opportunity for the organized sector (currently contributes ~22%). Driven by rising awareness and income level, organized players share s is expected to increase to 26% by 2020. PARAG is likely to be one of the key beneficiaries of this shift. Product portfolio shifting towards high margin products: VAP like cheese, whey protein enjoy higher gross margins of 25-45% versus 6-8% entailed in liquid milk. VAP forms ~66% to its revenue (the highest among the listed players versus 25-30% for others). With rising health awareness, its whey protein brand (Avvataar) could be a >`150 crore brand in next 2-3 years. Driven by recently launched products and higher share of VAP, its operating margins would improve to 10-11% in next few years. Reducing leverage and improving return ratios: PARAG is likely to incur a capex of ~`150 cr over FY2017-20 which is to be internally funded. With regular debt repayments, DE ratio is also likely to go down. With improving margins, its return ratios would normalize to 14-15% after making a temporary dip in FY2017. Outlook and valuation: We expect PARAG to report net revenue/pat CAGR of 13%/27% respectively over FY2018-20E. The stock currently trades at a P/E of 14.9x FY2020E EPS. It is increasingly becoming a stable brand strory while it is still valued as commodity business. We feel that the company should somewhere start enjoying the valuation of FMCG companies. We initiate coverage on the stock with a BUY recommendation and Target Price of `333 (20x FY2020E EPS), an upside of 34% from the current levels. BUY CMP `249 Target Price `333 Investment Period 12 Months Stock Info Sector Market Cap (` cr) Dairy Products 2,092 Net Debt (` cr) 162 Beta 1.1 52 Week High / Low 319/206 Avg. Daily Volume 2,12,755 Face Value (`) 10 BSE Sensex 34,192 Nifty 10,480 Reuters Code PAMF.NS Bloomberg Code PARAG.IN Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 48.7 13.0 17.5 20.9 Abs. (%) 3m 1yr 3yr Sensex (1.4) 15.0 16.7 PARAG (13.4) 1.5 - Key Financials (Consolidated) Y/E March (Rs cr) FY2016 FY2017E FY2018E FY2019E FY2020E Net Sales 1,645 1,731 1,957 2,214 2,498 % chg 13.9 5.2 13.1 13.1 12.9 Net Profit 49.4 35.9 86.7 116.3 140.2 % chg 33.0 (27.2) 141.4 34.1 20.5 OPM (%) 9.0 5.1 9.7 10.4 10.6 EPS (Rs) 5.9 4.3 10.3 13.8 16.7 P/E (x) 42.4 58.3 24.1 18.0 14.9 P/BV (x) 5.8 3.2 2.8 2.4 2.1 Price Chart 400 300 200 100 0 RoE (%) 13.6 5.5 11.7 13.5 14.0 Nidhi Agrawal RoCE (%) 15.3 4.3 14.3 16.6 18.0 022 3935 7800 Ext: 6872 EV/Sales (x) 1.5 1.3 1.1 1.0 0.9 nidhi.agrawal@angelbroking.com EV/EBITDA (x) 16.7 25.4 11.7 9.6 8.2 ; Note: closing price of April 13, 2018 Please refer to important disclosures at the end of this report 1

Initiating coverage Menon Bearings Parag Milk Foods in charts Exhibit 1: Organised dairy industry forms only 22% Exhibit 2: Liquid Milk forms the biggest chunk Organised 22% Unorganised 78% Paneer 7% Curd 5% Butter 4% Others 4% Liquid Milk 65% Ghee 15% Exhibit 3: Share of VAP to go up for Parag... 80% 60% 40% 20% Exhibit 4: Improving its margin profile 300 250 200 150 100 12.0% 10.0% 8.0% 6.0% 4.0% 0% FY14 FY15 FY16 FY17 FY18 FY19 FY20 Skimmed Milk Powder Liquid Milk 50 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 2.0% 0.0% Others-Job Work Value added products Operating profit (` cr) Operating margin (%) Exhibit 5: Revenue to grow well for next few years Exhibit 6: Return ratios normalising after FY2017 dip 3000 35% 35 2500 30% 30 2000 1500 1000 500 25% 20% 15% 10% 5% 25 20 15 10 5 0 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 0% - FY14 FY15 FY16 FY17 FY18 FY19 FY20 Net Sales- ` cr YoY chg (%) ROE % ROCE % April 16, 2018 2

Exhibit 7: Well diversified branded portfolio Company background PARAG started in 1992 to help farmers by collecting milk on milk holidays during Operation Flood. Back then, PARAG was primarily involved in the distribution and collection of milk. In 1998, the company set up Bhagyalaxmi Dairy Farm - India s most modern dairy farm with the finest international equipments. It manufactures a diverse range of products including cheese, ghee (clarified butter), fresh milk, whey proteins, paneer, curd, yoghurt, milk powders and dairy based beverages. Gowardhan and Go, its flagship brands, are among the leading ghee, cheese and other value added product brands in India. It also supply farm-to-home premium fresh milk from Bhagyalaxmi Dairy Farm, which it market and sell under Pride of Cows brand in Mumbai and Pune. Source: Company Milk procurement and processing capabilities Its 3-tier milk procurement system involves over 2,00,000 farmers from 29 districts of Maharashtra, Andhra Pradesh, Karnataka and Tamil Nadu through more than 3,400 village-level milk collection centres collecting nearly 1.2 million litres of milk every day. It has two manufacturing plants at Manchar in Maharashtra and Palamaner in Andhra Pradesh. Its current processing capacity is 2 million litres per day between two plants. It cheese capacity has been increased from 40 MT to 60 MT per day. It also has the first-of-its-kind whey processing plant and a fully automated Paneer plant with capacity of 20 MT per day. April 16, 2018 3

Exhibit 8: Procurement and distribution system of PARAG April 16, 2018 4

Investment Rationale Favorable market dynamics: 1. Shift from unorganized to organized Indian dairy industry is valued at `600000 cr+, growing at ~10%+ CAGR. This growth presents a strong opportunity for the organized sector which currently contributes ~22%. In India, over 80% of milk is consumed in the liquid form, as opposed to developed countries that consume a large portion of milk in the form of dairy products/vap. Driven by rising awareness, new products launch, aggressive marketing (by leading players) and income level, organized players share s is expected to increase to 26% by 2020. PARAG is likely to be one of the key beneficiaries of this shift. Exhibit 9: Currently >10% of the milk production is marketed by private players 2. Increasing health awareness and innovation Consumers are increasingly health conscious and are preferring nutritious, lowcarb, high-protein meals. They are experimenting with niche categories and therefore demand is fast growing for products like milk-based juice drinks, sports nutrition like whey protein, amongst others. ~31% of Indian population is vegetarian, for whom milk is a important source of vital nutrients. Over the past decade, VAPs have been rapidly growing due to: 1) Rising income levels due to a rising middle class and working population 2) Rising number of dual income households through increase in the number of working women 3) Increase in urban population 4) Rapidly expanding food service industry (Rise in HORECA - Hotels, Restaurants & Caterers segment) 5) Aggressive spending on advertisement and sales promotions by organised players to create awareness among consumers 3. Changing Dietary Patterns Over the years, the consumption trend has changed with people shifting from home-made dahi, ghee and paneer to branded products due to convenience in April 16, 2018 5

buying and higher assurance of quality. This has promoted the growth in demand for dairy and VAP. Product portfolio shifting towards high margin products Well established brands and diversified product portfolio PARAG has well recognized brands like Gowardhan and Go in its portfolio. It markets dairy products (milk, ghee, paneer, butter, etc) and processed cheese blocks under the Gowardhan brand. It has launched a wide range of cheese products, UHT, fresh cream etc, since 2008 under the Go brand which have gained good traction since their launches. Gowardhan has been recognized as the most trusted brand in the food products category and Go has been acknowledged as the Most Promising Brand in the FMCG category. Go cheese has been competing with products of the established market leader- Amul and has grabbed 33% of market share in a short span of 10 years. It has other brands like Pride of Cows (premium quality cow milk) and Topp Up (beverages). Exhibit 10: FY2017 revenue break-up UHT and chass lassi 5% Butter 9% Flavoured Milk 0% Whey 4% Cheese/ Paneer 21% Curd 5% Others-Job Work 2% Ghee 20% Skimmed Milk Powder 13% Liquid Milk 21% Source: Company Exhibit 11: Differentiated brand and product portfolio Source: Company April 16, 2018 6

Product portfolio shifting towards high margin products Value Added Products (VAP) like paneer, whey protein and cheese enjoy higher gross margins of 25-45% as compared to 6-8% margins entailed in liquid milk. VAP currently contributes ~66% to its revenue (highest in the industry as against 25-30% for other leading players). This is likely to touch 75% in next 2-3 years. Increasing VAP s revenue share will almost double its margins from 5.4% in FY2017 to 10.6% in FY2020. In M9FY2018, the company has registered a OPM of 9.6%, increased from 2.4% in M9FY2017. Exhibit 12: Product-wise revenue contribution and margins Source: Company Exhibit 13: Rising revenue share of VAP would boost margins FY20 FY19 FY18 FY17 FY16 FY15 FY14 0% 20% 40% 60% 80% 100% 120% Skimmed Milk Powder Liquid Milk Others-Job Work Value added products April 16, 2018 7

Exhibit 14: Improving margin profile 300 250 200 150 100 50 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 Operating profit (` cr) Operating margin (%) 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% New category holding good potential Whey protein under Avvatar brand Avvatar is the first Indian whey protein powder which is pure vegetarian and is derived from milk protein only and is soya free and sugar free. It is generated as a by-product during the manufacture of cheese. 1 kg cheese generates 50% (i.e 500 gms) of whey. This is a very good source of protein and is most sought after protein drink in the sports nutrition category. Till recently, the company was selling whey in crude form to the institutional segment. However, it has recently launched whey protein in retail under the Avvatar brand, which is sold directly to end consumers. The product is being distributed via tie ups with premium sports gyms, nutrition outlets and e-portals like Amazon. Whey protein market dominated by imports- PARAG can substitute Currently, the market is dominated by imported brands that constitute around 80-90% of the overall pie. The market size is estimated at `1500 cr, growing at 12-13% CAGR. The market is dominated by imported brands that dominates over 80% of the market as there is no domestic brand in the market. Hence, with introduction of Avvatar, Parag has become first mover in this category and can capture this high margin segment (40%) as the imported products become little dated while Avvatar being a local brand offers a fresher and effective substitute. Avvatar s revenue are expected to touch `20cr in FY2018. With a better distribution and marketing strategy, the product sale is expected to touch `100 cr in FY2019 and could be `150cr brand in another 1-2 years. April 16, 2018 8

Exhibit 15: Focus towards modern products which current forms only 10% of the organized market Source: Company Emerged as the leading player in cheese in a short span Cheese accounts for 21% of its FY2017 revenue and has grown to command 33% market share in Indian cheese market mainly driven by constant new product launch and aggressive marketing. Indian processed cheese market is valued at ~` 1000 cr market in FY2017 and is growing in excess of 15% for past couple of years. Amul is the market leader with 40% market share, Britannia-9% and Dynamix - 7%. The Indian fast food market is growing rapidly and cheese is quite popularly consumed with a number of fast foods such as Pizzas, Burgers, Garlic breads, and Sandwiches. Apart from western dishes, cheese is also being added as a taste enhancer in several traditional Indian recipes such as Dosas, Paratha, Pav Bhaji, amongst others. These trends would keep the buoyant demand for PARAG cheese segment. Reducing leverage and improving return ratios Demonetization and high raw milk procurement prices had led to poor performance in FY2017. With improving margins, its return ratios would also return to 14-15% from the temporary dip made in FY2017. Debt is expected to reduce over the next three years from the stabilization of profitability since FY2018. The company is likely to invest over `150 cr over FY2017-20 in its manufacturing facilities which is to be funded by mix of IPO proceeds and internal accruals. The company is likely to generate ~`100 cr+ annually as operating cash inflow which would fund its annual capex plan of~ `50-60 cr. April 16, 2018 9

Exhibit 16: Improving return ratios 35 30 25 20 15 Exhibit 17: Capex to be largely funded internally 200 150 100 50 10 5 - FY14 FY15 FY16 FY17 FY18 FY19 FY20 0 (50) FY14 FY15 FY16 FY17 FY18 FY19 FY20 Net Cash Flow From Operating Activities (` cr) ROE % ROCE % Free cash flow generated (` cr) Outlook We expect PARAG to report net revenue/pat CAGR of 13%/27% respectively over FY2018-20E driven by new product launch in VAP and reduction in interest cost. When compared with its peers, its revenue growth is largely in line. However, due to increasing share of VAP ( which is already highest among the listed players), its margin expansion will also be highest in the industry in FY2020. Exhibit 18: Peer financial comparison Revenue (` cr) CAGR % EBITDA (` cr) EBITDA Margin % Company name FY17 FY18 FY19 FY20 FY18 FY19 FY20 FY18 FY19 FY20 Hatsun Agro 4190 4790 5850 6837 17.7% 445 445 445 9.3% 7.6% 6.5% Heritage Foods 2573 2593 3022 3521 11.0% 142 197 252 5.5% 6.5% 7.2% Prabhat 1410 1599 1822 2082 13.9% 139 139 139 8.7% 7.6% 6.7% Parag 1731 1957 2214 2498 13.0% 191 229 265 9.7% 10.4% 10.6% Source: Bloomberg, Angel Research Valuation The stock currently trades at a P/E of 14.9x its FY2020E EPS which looks very attractive, looking its stable growth trajectory. The company is increasingly becoming a stable brand play while it is still valued as a commodity business. We feel that the company should somewhere start enjoying the valuation of FMCG companies. When compared with peers also, the company is trading at substantial discount to most of its peers. Hence,we initiate coverage on the stock with a BUY recommendation and Target Price of `333 (20x FY2020E EPS), an upside of 34% from the current levels. April 16, 2018 10

May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Initiating coverage Parag Milk Foods Exhibit 19: Peer valuation comparison (`) EPS (`) EPS CAGR % P/E (x) ROE (%) CMP FY17 FY18 FY19 FY20 FY18 FY19 FY20 FY17 FY18 FY19 FY20 Hatsun Agro 737 8.8 9.9 15.0 20.5 32.4 74.8 49.3 36.0 46.4 34.1 38.9 38.8 Heritage Foods 750 14.4 14.2 20.9 28.9 26.1 52.7 35.9 25.9 24.7 20.8 24.4 25.3 Prabhat Dairy 177 3.5 4.9 6.9 9.4 39.3 36.4 25.6 18.8 7.0 6.5 8.7 10.8 Parag Milk Foods 249 4.3 10.3 13.8 16.7 57.4 24.1 18.0 14.9 5.5 11.7 13.5 14.0 Exhibit 20: Forward PE chart 600.0 500.0 400.0 300.0 200.0 100.0 0.0 Closing price 10.0 X 15.0 X 20.0 X 25.0 X 30.0 X Risks and concerns Inability to procure sufficient good quality raw milk at commercially viable prices may adversely impact the operation as milk is a key raw material for all dairy products. The dairy industry is highly competitive with multiple players sourcing milk from the same region and price war. Such competition can have an impact on raw milk prices. The company is subject to various regulations relating to product liability, particularly relating to food safety of its products. Product contamination or similar occurrences can result in regulatory actions against the company and impact the business performance. April 16, 2018 11

Income statement Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Total operating income 1,645 1,731 1,957 2,214 2,498 % chg 13.9 5.2 13.1 13.1 12.9 Total Expenditure 1,497 1,642 1,767 1,984 2,233 Raw Material 1,333 1,414 1,520 1,710 1,924 Personnel 67 79 86 93 105 Selling and Administration Expenses 82.4 113.1 121.4 137.2 154.9 Others Expenses 15 36 39 44 50 EBITDA 148 89 191 229 265 % chg 38.2 (40.1) 114.7 20.3 15.4 (% of Net Sales) 9.0 5.1 9.7 10.4 10.6 Depreciation& Amortisation 33 49 54 59 65 EBIT 115 40 136 170 200 % chg 44.1 (65.3) 242.9 24.5 17.7 (% of Net Sales) 7.0 2.3 7.0 7.7 8.0 Interest & other Charges 50 33 24 18 13 Other Income 2 11 5 5 5 (% of PBT) 2.3 62.7 4.3 3.2 2.6 Share in profit of Associates - - - - - Recurring PBT 67 18 117 157 192 % chg 94.9 (73.8) 569.1 34.1 22.2 Tax 19 0 30 41 52 (% of PBT) 29.2 2.3 26.0 26.0 27.0 PAT (reported) 47 17 87 116 140 Extraordinary Items (2) (19) - - - Less: Minority interest (MI) 0 0 0 0 0 PAT after MI (reported) 47 17 87 116 140 ADJ. PAT 49 36 87 116 140 % chg 33.0 (27.2) 141.4 34.1 20.5 (% of Net Sales) 3.0 2.1 4.4 5.3 5.6 Fully Diluted EPS (`) 5.9 4.3 10.3 13.8 16.7 % chg 33.0 (27.2) 141.4 34.1 20.5 April 16, 2018 12

Balance sheet Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E SOURCES OF FUNDS Equity Share Capital 70 84 84 84 84 Reserves& Surplus 291 573 659 775 914 Shareholders Funds 362 657 743 859 998 Equity Share Warrants - - - - - Total Loans 389 262 212 162 112 Deferred Tax Liability - - - - - Other liabilties 18.7 18.1 18.1 18.1 18.1 Total Liabilities 769 938 974 1,039 1,129 APPLICATION OF FUNDS Gross Block 528 585 645 705 765 Less: Acc. Depreciation 183 226 280 340 404 Net Block 345 359 365 365 361 Capital Work-in-Progress 28 21 21 21 21 Investments - - - - - Current Assets 602 878 916 1,004 1,120 Inventories 272 429 456 515 582 Sundry Debtors 236 215 241 273 308 Cash 8 101 68 45 38 Loans & Advances 85 133 151 171 193 Other Assets - - - - - Current liabilities 211 382 411 462 520 Net Current Assets 391 496 505 542 600 Deferred Tax Asset (11) (10) (11) (12) (12) Total Assets 769 938 974 1,039 1,129 April 16, 2018 13

Cash flow statement Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Profit before tax 67 18 117 157 192 Depreciation 33 49 54 59 65 Change in Working Capital 0 0 (42) (60) (65) Interest / Dividend (Net) 47 25 24 18 13 Direct taxes paid (14) (16) (30) (41) (52) Others (75) (11) 0 0 0 Cash Flow from Operations 59 64 123 134 152 (Inc.)/ Dec. in Fixed Assets (27) (97) (60) (60) (60) (Inc.)/ Dec. in Investments (4) 6 (22) (28) (37) Cash Flow from Investing (31) (91) (82) (88) (97) Issue of Equity 6 278 0 0 0 Inc./(Dec.) in loans 60 0 (50) (50) (50) Dividend Paid (Incl. Tax) 0 0 0 0 0 Interest / Dividend (Net) (55) (31) (24) (18) (13) Cash Flow from Financing (26) 123 (74) (68) (63) Inc./(Dec.) in Cash 1 96 (33) (22) (7) Opening Cash balances 4 5 101 68 45 Closing Cash balances 5 101 68 45 38 April 16, 2018 14

Key Ratios Y/E March FY2016 FY2017 FY2018E FY2019E FY2020E Valuation Ratio (x) P/E (on FDEPS) 42.4 58.3 24.1 18.0 14.9 P/CEPS 26.0 31.7 14.9 11.9 10.2 P/BV 5.8 3.2 2.8 2.4 2.1 Dividend yield (%) 0.1 0.2 0.0 0.0 0.0 EV/Sales 1.5 1.3 1.1 1.0 0.9 EV/EBITDA 16.7 25.4 11.7 9.6 8.2 EV / Total Assets 3.2 2.4 2.3 2.1 1.9 Per Share Data (`) EPS (fully diluted) 5.9 4.3 10.3 13.8 16.7 Cash EPS 9.6 7.9 16.7 20.9 24.4 DPS 0.2 0.4 0.1 0.1 0.1 Book Value 43.0 78.2 88.4 102.1 118.7 Dupont Analysis EBIT margin 7.0 2.3 7.0 7.7 8.0 Tax retention ratio 0.7 1.0 0.7 0.7 0.7 Asset turnover (x) 2.2 2.1 2.2 2.3 2.3 ROIC (Post-tax) 10.9 4.8 11.4 12.9 13.6 Cost of Debt (Post Tax) 0.1 0.1 0.1 0.1 0.1 Returns (%) ROCE 15.3 4.3 14.3 16.6 18.0 Angel ROIC (Pre-tax) 15.5 4.9 15.4 17.4 18.7 ROE 13.6 5.5 11.7 13.5 14.0 Turnover ratios (x) Asset Turnover (Gross Block) 3.1 3.0 3.0 3.1 3.3 Inventory / Sales (days) 60 90 85 85 85 Receivables (days) 52 45 45 45 45 Payables (days) 58 99 99 99 99 Working capital cycle (ex-cash) (days) 55 37 31 31 31 Solvency ratios (x) Net debt to equity 1.1 0.2 0.2 0.1 0.1 Net debt to EBITDA 2.6 1.8 0.8 0.5 0.3 Interest Coverage (EBIT / Interest) 2.3 1.2 5.6 9.5 15.3 ; Note: closing price of April 13, 2018 April 16, 2018 15

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER - Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Pvt. Limited and its affiliates may have investment positions in the stocks recommended in this report. Disclosure of Interest Statement Parag Milk Foods Ltd. 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) April 16, 2018 16